REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings (RVPH) shows no detected cyber incidents or red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the near term. However, a clean recent period does not eliminate underlying risks typical of early-stage biotech; the absence of signal in a narrow timeframe masks longer-term exposure. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk from equity issuances, maps financing history, and flags AI-detected risk signals across income statement and cash burn trends. The full $49 Report adds quantified dilution trajectory, 12-month red-flag context, and forward cash runway assessment.